Margolis R K, Rauch U, Maurel P, Margolis R U
Department of Pharmacology, State University of New York, Brooklyn 11203, USA.
Perspect Dev Neurobiol. 1996;3(4):273-90.
Neurocan is a multidomain hyaluronan-binding chondroitin sulfate proteoglycan that is synthesized by neurons, whereas the astroglial proteoglycan phosphacan is an mRNA splice variant representing the entire extracellular portion of a receptor-type protein tyrosine phosphatase. A glycoform of phosphocan (phosphocan-KS) that contains both chondroitin sulfate and keratan sulfate is present in the postnatal rat central nervous system (CNS). The concentration of neurocan in brain increases during late embryonic development but then declines steeply during the early postnatal period together with hyaluronan, and neurocan also undergoes extensive proteolytic processing during the course of brain development. In contrast, the concentrations of both phosphocan and phosphocan-KS rise steadily after embryonic day 20 to reach a plateau at about 2 weeks postnatally. In the embryonic CNS the distribution of neurocan mRNA is more widespread than that of phosphocan, which is primarily present in regions of active cell proliferation. Neurocan mRNA is also present in areas where the proteoglycan is not expressed, and there is evidence that the short open reading frame in its 5'-leader may function as a cis-acting regulatory signal for the modulation of neurocan expression in the developing CNS. Neurocan and phosphocan bind saturably, reversibly, and with high affinity to neural cell adhesion molecules (Ng-CAM/L1, NCAM, TAG-1/axonin-1) and to tenascin-C. The proteoglycans and their ligands have overlapping localizations in the CNS, and binding of phosphocan to Ng-CAM/L1, NCAM, and tenascin-C is mediated by complex-type N-linked oligosaccharides on the proteoglycan. Neurocan and phosphocan also bind to neurons and are potent inhibitors of neuronal and glial adhesion and neurite outgrowth. Through their interactions with neural cell adhesion and extracellular matrix molecules, these proteoglycans may play a major role in modulating cell adhesion, neurite growth, and signal transduction across the plasma membrane during the development of the CNS.
神经黏蛋白是一种由神经元合成的多结构域透明质酸结合硫酸软骨素蛋白聚糖,而星形胶质细胞蛋白聚糖磷酸黏蛋白是一种mRNA剪接变体,代表受体型蛋白酪氨酸磷酸酶的整个细胞外部分。一种同时含有硫酸软骨素和硫酸角质素的磷酸黏蛋白糖型(磷酸黏蛋白-KS)存在于出生后大鼠中枢神经系统(CNS)中。神经黏蛋白在脑内的浓度在胚胎发育后期升高,但在出生后早期与透明质酸一起急剧下降,并且神经黏蛋白在脑发育过程中也经历广泛的蛋白水解加工。相比之下,磷酸黏蛋白和磷酸黏蛋白-KS的浓度在胚胎第20天之后稳步上升,在出生后约2周达到平台期。在胚胎中枢神经系统中,神经黏蛋白mRNA的分布比磷酸黏蛋白更广泛,磷酸黏蛋白主要存在于活跃细胞增殖区域。神经黏蛋白mRNA也存在于不表达蛋白聚糖的区域,并且有证据表明其5'-前导区的短开放阅读框可能作为一种顺式作用调节信号,用于调节发育中的中枢神经系统中神经黏蛋白的表达。神经黏蛋白和磷酸黏蛋白以饱和、可逆且高亲和力的方式与神经细胞黏附分子(Ng-CAM/L1、NCAM、TAG-1/轴突素-1)和腱生蛋白-C结合。蛋白聚糖及其配体在中枢神经系统中有重叠的定位,并且磷酸黏蛋白与Ng-CAM/L1、NCAM和腱生蛋白-C的结合是由蛋白聚糖上的复合型N-连接寡糖介导的。神经黏蛋白和磷酸黏蛋白也与神经元结合,并且是神经元和神经胶质细胞黏附以及神经突生长的有效抑制剂。通过它们与神经细胞黏附和细胞外基质分子的相互作用,这些蛋白聚糖可能在中枢神经系统发育过程中调节细胞黏附、神经突生长和跨质膜信号转导方面发挥主要作用。